日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study

HER2阳性转移性乳腺癌患者的完全缓解：一项真实世界的SONABRE研究

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104583
Ding, Nan; Visserman, Renee; Geurts, Sandra M E; Tol, Jolien; Vriens, Birgit E P J; Aaldering, Kirsten N A; Boon, Eline; Dercksen, Marcus W; van den Berkmortel, Franchette; Pepels, Manon J A E; Peters, Natascha A J B; Heijns, Joan B; van de Winkel, Linda; de Fallois, Aude J O; Tjan-Heijnen, Vivianne C G; de Boer, Maaike
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry

BMI对HR+/HER2-晚期乳腺癌患者预后的影响：一项基于SONABRE注册研究的分析

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-07108-6
Lammers, Senna W M; Thurisch, Hannah; Vriens, Ingeborg J H; Meegdes, Marissa; Engelen, Sanne M E; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Peters, Natascha A J B; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Teeuwen, Nathalie J A; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

SONABRE注册研究分析了新诊断为HER2阳性转移性乳腺癌患者的真实世界治疗模式和生存期的时间趋势。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-07235-0
Geurts, Sandra M E; Ibragimova, Khava I E; Ding, Nan; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; van de Wouw, Agnes J; Maaskant, Sabrina A J G; Teeuwen-Dedroog, Nathalie J A; van Nijnatten, Thiemo J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

HER2阳性晚期乳腺癌患者前四线治疗的疗效：来自SONABRE注册研究的结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06832-9
Ibragimova, Khava I E; Geurts, Sandra M E; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; Teeuwen-Dedroog, Nathalie J A; Vriens, Ingeborg J H; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry

CDK 4/6抑制剂的应用及其对HR+/HER2-晚期乳腺癌患者治疗选择的影响：一项来自荷兰SONABRE注册研究

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.33785
Meegdes, Marissa; Geurts, Sandra M E; Erdkamp, Frans L G; Dercksen, Marcus Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Teeuwen, Nathalie J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

初始激素受体/HER2亚型是晚期乳腺癌亚型不一致的主要决定因素：一项基于SONABRE登记研究的调查。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06472-5
Meegdes, Marissa; Ibragimova, Khava I E; Lobbezoo, Dorien J A; Vriens, Ingeborg J H; Kooreman, Loes F S; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Peters, Natascha A J B; Hochstenbach-Waelen, Ananda; Smidt, Marjolein L; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

帕妥珠单抗和T-DM1治疗HER2阳性晚期乳腺癌前后生存情况：SONABRE注册研究

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06178-8
Ibragimova, Khava I E; Geurts, Sandra M E; Croes, Sander; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Aaldering, Kirsten N A; Dercksen, Marcus W; Pepels, Manon J A E; Peters, Natascha A J B; van de Winkel, Linda; Tilli, Dominique J P; Vriens, Ingeborg J H; de Boer, Maaike; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Development of an Efficient G-Quadruplex-Stabilised Thrombin-Binding Aptamer Containing a Three-Carbon Spacer Molecule

开发一种含有三碳间隔分子的高效 G-四链体稳定凝血酶结合适体

期刊:Chembiochem
影响因子:2.6
doi:10.1002/cbic.201600654
Lukas J Aaldering, Vasanthanathan Poongavanam, Niels Langkjaer, N Arul Murugan, Per Trolle Jørgensen, Jesper Wengel, Rakesh N Veedu
发表日期：2017
文献求助 收藏

Political leaders and the media. Can we measure political leadership images in newspapers using computer-assisted content analysis?

政治领袖与媒体。我们能否利用计算机辅助内容分析来衡量报纸中政治领袖的形象？

期刊:Quality & Quantity
影响因子:
doi:10.1007/s11135-015-0242-9
Aaldering, Loes; Vliegenthart, Rens
发表日期：2016
文献求助 收藏

Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells

壳聚糖-microRNA 纳米复合物向 MCF-7 乳腺癌细胞传递基因的物理化学和生物学表征

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/srep13567
B Santos-Carballal, L J Aaldering, M Ritzefeld, S Pereira, N Sewald, B M Moerschbacher, M Götte, F M Goycoolea
免疫
细胞生物学
乳腺癌
肿瘤细胞
发表日期：2015
文献求助 收藏